Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Moody's: Patent-cliff challenges will continue to dog big pharma
Moody's: Patent-cliff challenges will continue to dog big pharma
Moody's: Patent-cliff challenges will continue to dog big pharma
Submitted by
admin
on February 4, 2015 - 1:43pm
Source:
BioPharma Dive
News Tags:
patents
patent cliff
Big Pharma
Pfizer
Eli Lilly
Merck
Amgen
Novo Nordisk
AstraZeneca
Bristol-Myers Squibb
Headline:
Moody's: Patent-cliff challenges will continue to dog big pharma
Do Not Allow Advertisers to Use My Personal information
